Prozinc 40 Unit Suspension is a Health Canada–registered veterinary drug (DIN 02405202) held by Boehringer Ingelheim Animal Health Canada Inc., containing Insulin (Human). Health Canada lists its status as Marketed (status date 28 Feb 2020). Nexara Health has matched 490 registrations of Insulin (Human) across 26 other regulated markets.
Health Canada registration
| DIN | 02405202 |
|---|---|
| Brand name | Prozinc |
| Active ingredient | Insulin (Human) |
| Strength | 40 Unit |
| Dosage form | Suspension |
| Route | Subcutaneous |
| Company | Boehringer Ingelheim Animal Health Canada Inc. |
| Status | Marketed — 28 Feb 2020 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Insulin (Human) registered in other markets
490 registrations of the same molecule in 26 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Austria | Huminsulin "Lilly" Basal 100 IE/ml Inj.susp. Patronen | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Huminsulin "Lilly" Basal 100 IE/ml KwikPen | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Huminsulin "Lilly" Profil III 100 IE/ml Inj.susp. Patronen | — | 5St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Actrapid | Novo Nordisk A/S, Denmark. | 100 IU/ML | Solution For Injection | POM | NHRA |
| Bahrain | Insulatard | Novo Nordisk A/S, Denmark. | 100 IU/ML | Suspension For Injection | POM | NHRA |
| Bahrain | Mixtard 30 | Novo Nordisk A/S, Denmark. | 100 IU/ML | Suspension For Injection | POM | NHRA |
| Bolivia | Insulina recombinante humana NPH | — | 100 UI/ml | Inyectable | LINAME (formulary) | |
| Czech Republic | Actraphane 30 | — | 40IU/ML | Inj Sus Via | R | SUKL DLP |
| Czech Republic | Actraphane 30 | — | 100IU/ML | Inj Sus Via | R | SUKL DLP |
| Czech Republic | Actraphane 30 | — | 40IU/ML | Inj Sus Via | R | SUKL DLP |
| Czech Republic | Actraphane 30 | — | 40IU/ML | Inj Sus Via | R | SUKL DLP |
| Czech Republic | Actraphane 30 | — | 100IU/ML | Inj Sus Via | R | SUKL DLP |
| Czech Republic | Actraphane 30 | — | 100IU/ML | Inj Sus Via | R | SUKL DLP |
| Czech Republic | Actraphane 30 Flexpen | — | 100IU/ML | Inj Sus Pep | R | SUKL DLP |
| Czech Republic | Actraphane 30 Flexpen | — | 100IU/ML | Inj Sus Pep | R | SUKL DLP |
| European Union (EMA) | Actraphane | Novo Nordisk A/S | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Actrapid | Novo Nordisk A/S | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Combimarv | Marvel Life Sciences Ltd. | Application withdrawn | EMA centrally authorised | ||
| European Union (EMA) | Exubera | Pfizer Limited | Withdrawn | EMA centrally authorised | ||
| European Union (EMA) | Inpremzia | Baxter Holding B.V. | Withdrawn | EMA centrally authorised | ||
| European Union (EMA) | Insulatard | Novo Nordisk A/S | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Insulin Human 30/70 Mix Marvel | Marvel LifeSciences Ltd. | Application withdrawn | EMA centrally authorised | ||
| European Union (EMA) | Insulin Human Long Marvel | Marvel LifeSciences Ltd. | Application withdrawn | EMA centrally authorised | ||
| Hong Kong | Actrapid Flexpen Solution For Injection In Pre-Filled Pen 100iu/mL | Novo Nordisk Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Actrapid Hm Penfill Neutral Inj 100iu/mL | Novo Nordisk Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Actrapid Penfill Inj 100iu/mL (Brazil) | Novo Nordisk Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Actrapid Solution For Injection 100iu/mL | Novo Nordisk Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Humulin R Inj 100 IU/mL | Eli Lilly Asia, Inc. | Registered | DH Drug Office | ||
| Hong Kong | Humulin R Insulin Inj 100iu/mL-Cartridge | Eli Lilly Asia, Inc. | Registered | DH Drug Office | ||
| Hong Kong | Insulin Actrapid Hm Inj 100iu/mL | Novo Nordisk Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Scilin R Inj 100 IU/mL (Cartridge) | Keen Health Limited | Registered | DH Drug Office | ||
| Hungary | Actrapid Penfill 100 Nemzetközi Egység/mL Oldatos Injekció Patronban | Novo Nordisk A/S | 5x3ml patronban | NEAK PUPHA | ||
| Hungary | Humulin M3 (30/70) 100 Ne/mL Szuszpenziós Injekció Patronban | Eli Lilly Nederland B.V. | 5x3ml patronban | NEAK PUPHA | ||
| Hungary | Humulin N 100 Ne/mL Szuszpenziós Injekció Patronban | Eli Lilly Nederland B.V. | 5x3ml patronban | NEAK PUPHA | ||
| Hungary | Humulin R 100 Ne/mL Oldatos Injekció Patronban | Eli Lilly Nederland B.V. | 5x3ml patronban | NEAK PUPHA | ||
| Hungary | Insulatard 100 Ne/mL Szuszpenziós Injekció Injekciós Üvegben (10 mL) | Novo Nordisk A/S | 1x10 ml | NEAK PUPHA | ||
| Hungary | Insulatard Penfill 100 Ne/mL Szuszpenziós Injekció Patronban | Novo Nordisk A/S | 5x3ml | NEAK PUPHA | ||
| Hungary | Insuman Basal 100 Ne/mL Szuszpenziós Injekció Patronban | Sanofi-Aventis Pharma Deutschland GmbH | 5x3ml | NEAK PUPHA | ||
| Hungary | Insuman Basal Solostar 100 Ne/mL Szuszpenziós Injekció Előretöltött Injekciós Tollban | Sanofi-Aventis Pharma Deutschland GmbH | 5x3ml előretöltött injekciós tollban | NEAK PUPHA | ||
| Iceland | Actrapid | Novo-Nordisk A/S | 100 ae/ml | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Insulatard | Novo-Nordisk A/S | 100 ae/ml | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Insulatard FlexPen | Novo-Nordisk A/S | 100 ae/ml | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | ProZinc | Vistor - óskráð | 40 ae | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Actraphane | Novo Nordisk A/S | Solution for injection | Unknown | HPRA | |
| Ireland | Actraphane 30 40 IU/ml Suspension for injection | Novo Nordisk A/S | Suspension for injection | Unknown | HPRA | |
| Ireland | Actrapid | Novo Nordisk A/S | Solution for injection | Unknown | HPRA | |
| Ireland | Actrapid | Novo Nordisk A/S | Solution for injection | Unknown | HPRA | |
| Ireland | Insulatard | Novo Nordisk A/S | Suspension for injection | Unknown | HPRA | |
| Ireland | Insulatard 100 international units/ml suspension for injection in vial | Novo Nordisk A/S | Suspension for injection | Unknown | HPRA | |
| Ireland | Insulatard FlexPen | Novo Nordisk A/S | Suspension for injection | Unknown | HPRA | |
| Ireland | Insulatard InnoLet | Novo Nordisk A/S | Suspension for injection | Unknown | HPRA | |
| Jordan | Jusline R | Gulf pharmaceutical industries (Julphar) | 100 INTERNATIONAL UNIT/1 MILLILITER | Solution for injection | NEW APPLICATION | JFDA drug registrations |
| Luxembourg | Humuline 30/70 Cartridge SP.INJ.CART. 100 UI / 1 mL 1*5 cartouches 3 mL | — | R | CNS liste positive | ||
| Luxembourg | Humuline NPH Cartridge SP.INJ.CART. 100 UI / 1 mL 1*5 cartouches 3 mL | — | R | CNS liste positive | ||
| Luxembourg | INSULATARD SP.INJ. 100 UI / 1 mL 1*1 FL. 10 ML | — | R | CNS liste positive | ||
| Malaysia | Actrapid 100 IU/ml Solution for Injection | Novo Nordisk Pharma (Malaysia) Sdn. Bhd. | Biologics | CONDITIONAL REGISTRATION | NPRA | |
| Malaysia | Actrapid 100 IU/ml Solution for Injection in Vial | Novo Nordisk Pharma (Malaysia) Sdn. Bhd. | Biologics | PRODUCT APPROVED | NPRA | |
| Malaysia | Actrapid FlexPen 100 IU/ml Solution for Injection in Pre-filled Pen | Novo Nordisk Pharma (Malaysia) Sdn. Bhd. | Biologics | PRODUCT APPROVED | NPRA | |
| Malaysia | Diabulyn - 30/70 (Biphasic) Insulin Injection, Biphasic Isophane 100 IU/mL | Biocon Sdn Bhd | Biologics | CONDITIONAL REGISTRATION | NPRA | |
| Malaysia | Diabulyn - N (NPH) Insulin Injection, Isophane 100 IU/mL | Biocon Sdn Bhd | Biologics | CONDITIONAL REGISTRATION | NPRA | |
| Malaysia | Diabulyn - R (Regular) Insulin Injection, Soluble 100 IU/mL | Biocon Sdn Bhd | Biologics | CONDITIONAL REGISTRATION | NPRA | |
| Malaysia | Gensulin N 100 IU/ml suspension for injection | Pharmaniaga Marketing Sdn Bhd | Biologics | CONDITIONAL REGISTRATION | NPRA | |
| Malaysia | Gensulin R 100 IU/ml solution for injection | Pharmaniaga Marketing Sdn Bhd | Biologics | CONDITIONAL REGISTRATION | NPRA | |
| Malta | Gensulin R 100 IU/ml solution for injection | Bioton SA | Solution For Injection | Authorised | Medicines Authority | |
| Malta | Humulin I (Isophane) 100IU/ml Suspension for Injection in cartridge | Eli Lilly Nederland B.V | Suspension For Injection | Authorised | Medicines Authority | |
| Malta | Humulin M3 (Mixture 3) 100IU/ml Suspension for Injection in cartridge | Eli Lilly Nederland B.V | Suspension For Injection | Authorised | Medicines Authority | |
| Malta | Humulin S (Soluble) 100IU/ml Suspension for Injection in cartridge | Eli Lilly Nederland B.V | Solution For Injection | Authorised | Medicines Authority | |
| Netherlands | Actrapid 40 internationale eenheden/ml oplossing voor injectie in injectieflacon | Novo Nordisk A.S. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Humuline NPH KwikPen, suspensie voor injectie 100 IE/ml, 3 ml | Euro Registratie Collectief B.V. | Suspensie voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Humuline NPH KwikPen, suspensie voor injectie 100 IE/ml, 3 ml | Eli Lilly Nederland B.V. | Suspensie voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Humuline NPH patroon, suspensie voor injectie 100 IE/ml, 3,0 ml | Medcor Pharmaceuticals B.V. | Suspensie voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Humuline NPH patroon, suspensie voor injectie 100 IE/ml, 3,0 ml | Eli Lilly Nederland B.V. | Suspensie voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Humuline Regular patroon, oplossing voor injectie 100 IE/ml, 3,0 ml | Euro Registratie Collectief B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Humuline Regular patroon, oplossing voor injectie 100 IE/ml, 3,0 ml | Medcor Pharmaceuticals B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Humuline Regular patroon, oplossing voor injectie 100 IE/ml, 3,0 ml | Eli Lilly Nederland B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Poland | Actraphane 30 | Novo Nordisk A/S | 40 j.m./ml (co odpowiada 1,4 mg) | Zawiesina do wstrzykiwań w fiolce | URPL RPL | |
| Poland | Actraphane 30 | Novo Nordisk A/S | 100 j.m./ml (3,5 mg/ml) | Zawiesina do wstrzykiwań w fiolce | URPL RPL | |
| Poland | Actraphane 30 FlexPen | Novo Nordisk A/S | 100 j.m./ml (3,5 mg/ml) | Zawiesina do wstrzykiwań | URPL RPL | |
| Poland | Actraphane 30 InnoLet | Novo Nordisk A/S | 100 j.m./ml (3,5 mg/ml) | Zawiesina do wstrzykiwań | URPL RPL | |
| Poland | Actraphane 30 Penfill | Novo Nordisk A/S | 100 j.m./ml (3,5 mg/ml) | Zawiesina do wstrzykiwań | URPL RPL | |
| Poland | Actraphane 40 Penfill | Novo Nordisk A/S | 100 j.m./ml (3,5 mg/ml) | Zawiesina do wstrzykiwań | 2024-02-02 | URPL RPL |
| Poland | Actraphane 50 Penfill | Novo Nordisk A/S | 100 j.m./ml (3,5 mg/ml) | Zawiesina do wstrzykiwań | URPL RPL | |
| Poland | Actrapid | Novo Nordisk A/S | 100 j.m./ml (3,5 mg/ml) | Roztwór do wstrzykiwań | URPL RPL | |
| Romania | HUMULIN M3 100 UI/ml | — | 100UI/ml | Susp. Inj. In Cartus | PRF | ANMDMR nomenclator |
| Romania | HUMULIN M3 100 UI/ml | — | 100UI/ml | Susp. Inj. In Cartus | PRF | ANMDMR nomenclator |
| Romania | HUMULIN M3 KwikPen 100 UI/ml | — | 100UI/ml | Susp. Inj. | PRF | ANMDMR nomenclator |
| Romania | HUMULIN M3 KwikPen 100 UI/ml | — | 100UI/ml | Susp. Inj. | PRF | ANMDMR nomenclator |
| Romania | HUMULIN M3 KwikPen 100 UI/ml | — | 100UI/ml | Susp. Inj. | PRF | ANMDMR nomenclator |
| Romania | HUMULIN N KwikPen 100 UI/ml | — | 100UI/ml | Susp. Inj. | PRF | ANMDMR nomenclator |
| Romania | HUMULIN N KwikPen 100 UI/ml | — | 100UI/ml | Susp. Inj. | PRF | ANMDMR nomenclator |
| Romania | HUMULIN N KwikPen 100 UI/ml | — | 100UI/ml | Susp. Inj. | PRF | ANMDMR nomenclator |
| Saudi Arabia | Humulin-L Lente 100 U-mL | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Humulin-R 100u-mL Cartridge | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Humulin-R-Regular 100 U-mL | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Insulatard | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Ultratard Hm 100 I.u. Vial | — | 100 | Inactive | SFDA | |
| Serbia | Actrapid® FlexPen® | Novo Nordisk Pharma Doo Beograd | OBNOVA | ALIMS | ||
| Serbia | Actrapid® Penfill® | Novo Nordisk Pharma Doo Beograd | OBNOVA | ALIMS | ||
| Serbia | Humulin® M3 | Predstavništvo Eli Lilly (Suisse) SA, Beograd (Novi Beograd) | OBNOVA | ALIMS | ||
| Serbia | Humulin® NPH | Predstavništvo Eli Lilly (Suisse) SA, Beograd (Novi Beograd) | OBNOVA | ALIMS | ||
| Serbia | Humulin® R | Predstavništvo Eli Lilly (Suisse) SA, Beograd (Novi Beograd) | OBNOVA | ALIMS | ||
| Serbia | Insulatard® FlexPen® | Novo Nordisk Pharma Doo Beograd | OBNOVA | ALIMS | ||
| Serbia | Insulatard® Penfill® | Novo Nordisk Pharma Doo Beograd | OBNOVA | ALIMS | ||
| Serbia | Mixtard® 30 FlexPen® | Novo Nordisk Pharma Doo Beograd | OBNOVA | ALIMS | ||
| Singapore | ACTRAPID INJECTION 100 IU/ml | Novo Nordisk Pharma (Singapore) Pte Ltd | 100IU/ml | Injection | Pharmacy Only | HSA |
| Slovenia | Actrapid Penfill 100 i.e./ml razt.za inj.vložek 3 ml 5x | — | P | CBZ | ||
| Slovenia | Humulin M3 100 i.e./ml susp.za inj. vložek 3 ml 5x | — | P | CBZ | ||
| Slovenia | Humulin M3 KwikPen 100 i.e./ml susp.za inj. peresnik 3 ml 5x | — | P | CBZ | ||
| Slovenia | Humulin N 100 i.e./ml susp.za inj. vložek 3 ml 5x | — | P | CBZ | ||
| Slovenia | Humulin N KwikPen 100 i.e./ml susp.za inj. peresnik 3 ml 5x | — | P | CBZ | ||
| Slovenia | Humulin R 100 i.e./ml razt.za inj. vložek 3 ml 5x | — | P | CBZ | ||
| Slovenia | Insulatard FlexPen 100 i.e./ml susp.injekc.peresnik 3 ml 5x | — | P | CBZ | ||
| Slovenia | Insulatard Penfill 100 i.e./ml susp.za inj. vložek 3 ml 5x | — | P | CBZ | ||
| South Africa | Insuman Comb 30/70 (300 IU/3 ml) | Sanofi Aventis South Africa (Pty) Ltd | 300 IU/3ml | Inj | Discontinued | DoH SEP database |
| Taiwan | Humulin 60/40 100iu/mL(60%Human Insulin Isophane Suspension &40%Human Insulin In | Lilly France S.a. | 滅菌懸液注射劑 | 已註銷 | TFDA | |
| Taiwan | Humulin 70/30 100 IU/mL | Lilly Deutschland GmbH | 滅菌懸液注射劑 | 已註銷 | TFDA | |
| Taiwan | Humulin 70/30 100iu/mL (Cartridges) | Lilly France | 滅菌懸液注射劑 | 已註銷 | TFDA | |
| Taiwan | Humulin 70/30 100iu/mL (Cartridges) | Lilly France S.a. | 滅菌懸液注射劑 | 已註銷 | TFDA | |
| Taiwan | Humulin 80/20 100iu/mL | Lilly France S.a. | 滅菌懸液注射劑 | 已註銷 | TFDA | |
| Taiwan | Humulin 80/20 100iu/mL | Lilly France S.a. | 滅菌懸液注射劑 | 已註銷 | TFDA |
See every manufacturer of Insulin (Human) worldwide →
Regulator price references for Insulin (Human)
Published list or reimbursement prices for Insulin (Human) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | Huminsulin "Lilly" Profil III 100 IE/ml Inj.susp. Patronen | 100iu/1ml | 5St | 35.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Huminsulin "Lilly" Basal 100 IE/ml Inj.susp. Patronen | 100iu/1ml | 5St | 35.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Huminsulin "Lilly" Basal 100 IE/ml KwikPen | 100iu/1ml | 5St | 37.35 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Mixtard 30 | 100iu/1ml | 10ML | 5.99 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Insulatard | 100iu/1ml | 10ML | 5.99 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Actrapid | 100iu/1ml | 10ML | 5.99 BHD | retail (max) | NHRA | 2026-09-01 |
| Hungary | Insulatard 100 Ne/mL Szuszpenziós Injekció Injekciós Üvegben (10 mL) | 10ml | 1x10 ml | 3,481.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insuman Comb 25 100 Ne/mL Szuszpenziós Injekció Patronban | 3ml | 5x3ml | 5,220.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insuman Comb 25 Solostar 100 Ne/mL Szuszpenziós Injekció Előretöltött Injekciós Tollban | 3ml | 5x3ml előretöltött injekciós tollban | 5,220.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insuman Rapid 100 Ne/mL Oldatos Injekció Patronban | 3ml | 5x3ml | 5,220.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insuman Basal 100 Ne/mL Szuszpenziós Injekció Patronban | 3ml | 5x3ml | 5,220.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insuman Comb 50 100 Ne/mL Szuszpenziós Injekció Patronban | 3ml | 5x3ml | 5,220.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Actrapid Penfill 100 Nemzetközi Egység/mL Oldatos Injekció Patronban | 3ml | 5x3ml patronban | 5,222.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insulatard Penfill 100 Ne/mL Szuszpenziós Injekció Patronban | 3ml | 5x3ml | 5,222.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insuman Basal Solostar 100 Ne/mL Szuszpenziós Injekció Előretöltött Injekciós Tollban | 3ml | 5x3ml előretöltött injekciós tollban | 5,898.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Insuman Rapid Solostar 100 Ne/mL Oldatos Injekció Előretöltött Injekciós Tollban | 3ml | 5x3 ml előretöltött injekciós tollban | 5,898.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Humulin N 100 Ne/mL Szuszpenziós Injekció Patronban | 3ml | 5x3ml patronban | 6,230.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Humulin R 100 Ne/mL Oldatos Injekció Patronban | 3ml | 5x3ml patronban | 6,230.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Humulin M3 (30/70) 100 Ne/mL Szuszpenziós Injekció Patronban | 3ml | 5x3ml patronban | 6,230.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Actrapid | hgl | 1,990.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | Insulatard | hgl | 2,172.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | Insulatard FlexPen | áfpen | 4,199.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | ProZinc | hgl | 8,467.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Luxembourg | INSULATARD SP.INJ. 100 UI / 1 mL 1*1 FL. 10 ML | 10ml+1ml | 16.74 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Humuline NPH Cartridge SP.INJ.CART. 100 UI / 1 mL 1*5 cartouches 3 mL | 1ml+3ml | 33.25 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Humuline 30/70 Cartridge SP.INJ.CART. 100 UI / 1 mL 1*5 cartouches 3 mL | 1ml+3ml | 33.33 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Saudi Arabia | Humulin-L Lente 100 U-mL | 100u | 53.55 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Humulin-R-Regular 100 U-mL | 100u | 53.55 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Ultratard Hm 100 I.u. Vial | 65.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Insulatard | 65.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Humulin-R 100u-mL Cartridge | 100u | 93.70 SAR | public | SFDA | 2026-09-01 | |
| South Africa | Insuman Comb 30/70 (300 IU/3 ml) | 300iu/3ml | 3 | 622.18 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | Jusline R U-100 | 100u/1ml | 10 ml Vial | 45.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Prozinc (DIN 02405202) marketed in Canada?
Yes. Health Canada lists DIN 02405202 as Marketed as of 28 Feb 2020.
Who holds the Canadian licence for this product?
Boehringer Ingelheim Animal Health Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Insulin (Human) registered outside Canada?
Yes — Nexara Health has matched 490 registrations in 26 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02405202, status date 2020-02-28; national medicine registries: ALIMS, ANMDMR nomenclator, CBZ, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, HPRA, HSA, JFDA drug registrations, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, NEAK PUPHA, NHRA, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02405202, status date 2020-02-28; national medicine registries: ALIMS, ANMDMR nomenclator, CBZ, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, HPRA, HSA, JFDA drug registrations, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, NEAK PUPHA, NHRA, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA, SFDA.
Boehringer Ingelheim Animal Health Canada Inc. — company profileWho else makes Insulin (Human)All Canadian Insulin (Human) products
Health Canada Drug Product Database (DPD), DIN 02405202, status date 2020-02-28; national medicine registries: ALIMS, ANMDMR nomenclator, CBZ, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, HPRA, HSA, JFDA drug registrations, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, NEAK PUPHA, NHRA, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.